Sunshine Biopharma (SBFM) Restructuring Costs (2010 - 2026)
Sunshine Biopharma's (SBFM) quarterly Restructuring Costs came in at $871608.0 in Q1 2026, down 5.86% YoY from $925878.0 in Q1 2025, and down 42.56% on a QoQ basis from $1.5 million in Q4 2025.
Sunshine Biopharma (SBFM) Restructuring Costs (2010 - 2026) Analysis & Trends
Sunshine Biopharma (SBFM) has 5 years of Restructuring Costs data on file, last reported at $871608.0 in Q1 2026.
- Quarterly Restructuring Costs fell 5.86% year-over-year to $871608.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 23.89% YoY) and the FY2025 annual result came in at $3.9 million, up 24.26% from the prior year.
- Restructuring Costs slipped to $871608.0 in Q1 2026, from $1.5 million in the prior quarter.
- In the past five years, Restructuring Costs ranged from a high of $1.5 million in Q4 2025 to a low of $530334.0 in Q3 2024.
- A 4-year average of $823777.3 and a median of $806605.0 in 2025 frame the typical range for Restructuring Costs.
- Annual changes were most pronounced in 2025 — Restructuring Costs jumped 67.48% — and 2026, when it declined 5.86%.
- Tracing SBFM's Restructuring Costs over 4 years: stood at $720297.0 in 2023, then grew by 25.79% to $906056.0 in 2024, then jumped by 67.48% to $1.5 million in 2025, then tumbled by 42.56% to $871608.0 in 2026.
- The last three Restructuring Costs figures came in at $871608.0 (Q1 2026), $1.5 million (Q4 2025), and $614661.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - |
| 10 | Sunshine Biopharma | 1.54 Mn | -12.21 Mn | 2.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 762,187.00 |
| Mar 31, 2026 | 871,608.00 |
| Dec 31, 2025 | 1.52 Mn |
| Sep 30, 2025 | 614,661.00 |
| Jun 30, 2025 | 806,605.00 |
| Mar 31, 2025 | 925,878.00 |
| Dec 31, 2024 | 906,056.00 |
| Sep 30, 2024 | 530,334.00 |
| Jun 30, 2024 | 713,245.00 |
| Mar 31, 2024 | 911,211.00 |
| Dec 31, 2023 | 720,297.00 |
| Sep 30, 2023 | 544,215.00 |
| Dec 31, 2010 | -155,150.00 |